» Articles » PMID: 36867201

Regional Brain Glucose Metabolism is Differentially Affected by Ketogenic Diet: a Human Semiquantitative Positron Emission Tomography

Overview
Date 2023 Mar 3
PMID 36867201
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Ketogenic diet (KD) is recommended to avoid intense [F]FDG myocardial physiologic uptake in PET imaging. Neuroprotective and anti-seizure effects of KD have been suggested, but their mechanisms remain to be elucidated. This [F]FDG PET study aims to evaluate the effect of KD on glucose brain metabolism.

Method: Subjects who underwent KD prior to whole-body and brain [F]FDG PET between January 2019 and December 2020 in our department for suspected endocarditis were retrospectively included. Myocardial glucose suppression (MGS) on whole-body PET was analyzed. Patients with brain abnormalities were excluded. Thirty-four subjects with MGS (mean age: 61.8 ± 17.2 years) were included in the KD population, and 14 subjects without MGS were considered for a partial KD group (mean age: 62.3 ± 15.1 years). Brain SUVmax was first compared between these two KD groups to determine possible global uptake difference. Semiquantitative voxel-based intergroup analyses were secondarily performed to determine possible inter-regional differences by comparing KD groups with and without MGS, separately, to 27 healthy subjects fasting for at least 6 h (mean age of 62.4 ± 10.9 years), and KD groups between them (p-voxel < 0.001, and p-cluster < 0.05, FWE-corrected).

Results: A 20% lower brain SUVmax was found in subjects under KD with MGS in comparison to those without MGS (Student's t-test, p = 0.02). Whole-brain voxel-based intergroup analysis revealed that patients under KD with and without MGS had relative hypermetabolism of limbic regions including medial temporal cortices and cerebellum lobes and relative hypometabolism of bilateral posterior regions (occipital), without significant difference between them.

Conclusion: KD globally reduces brain glucose metabolism but with regional differences, requiring special attention to clinical interpretation. On a pathophysiological perspective, these findings could help understand underlying neurological effects of KD through possible decrease of oxidative stress in posterior regions and functional compensation in the limbic regions.

Citing Articles

Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma.

Duraj T, Kalamian M, Zuccoli G, Maroon J, DAgostino D, Scheck A BMC Med. 2024; 22(1):578.

PMID: 39639257 PMC: 11622503. DOI: 10.1186/s12916-024-03775-4.


Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up [F]FDG-PET study.

Horowitz T, Dudouet P, Campion J, Kaphan E, Radulesco T, Gonzalez S Eur J Nucl Med Mol Imaging. 2024; 51(11):3215-3222.

PMID: 38862619 DOI: 10.1007/s00259-024-06775-x.


Current status and perspectives of nuclear cardiology.

Tamaki N, Manabe O Ann Nucl Med. 2023; 38(1):20-30.

PMID: 37891375 DOI: 10.1007/s12149-023-01878-1.


Optimization of Nutrition after Brain Injury: Mechanistic and Therapeutic Considerations.

Poblete R, Yaceczko S, Aliakbar R, Saini P, Hazany S, Breit H Biomedicines. 2023; 11(9).

PMID: 37760993 PMC: 10526443. DOI: 10.3390/biomedicines11092551.

References
1.
Sokoloff L . Metabolism of ketone bodies by the brain. Annu Rev Med. 1973; 24:271-80. DOI: 10.1146/annurev.me.24.020173.001415. View

2.
Magistretti P, Allaman I . A cellular perspective on brain energy metabolism and functional imaging. Neuron. 2015; 86(4):883-901. DOI: 10.1016/j.neuron.2015.03.035. View

3.
Paoli A, Rubini A, Volek J, Grimaldi K . Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013; 67(8):789-96. PMC: 3826507. DOI: 10.1038/ejcn.2013.116. View

4.
Williams G, Kolodny G . Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol. 2008; 190(2):W151-6. DOI: 10.2214/AJR.07.2409. View

5.
Ye F, Li X, Jiang W, Sun H, Liu J . Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. J Clin Neurol. 2015; 11(1):26-31. PMC: 4302176. DOI: 10.3988/jcn.2015.11.1.26. View